Nearly 697,000 people in the United States die of heart disease each year, making it the leading cause of death for both men and women. But what if a significant portion of that risk wasn’t tied to traditional factors like cholesterol and blood pressure, but to the trillions of microorganisms living in your gut? The … Read more
Nearly half of all adults over 30 show signs of periodontal disease. But what if the roots of this widespread condition, and the cardiovascular risks it carries, aren’t found in adulthood, but in childhood? A growing body of evidence suggests a direct and alarming link between oral health in youth and the development of heart … Read more
Susan Lucci, the actress synonymous with daytime television’s Erica Kane, is delivering a message far more vital than any plot twist she portrayed on All My Children: heart disease is a critical, often overlooked, threat to women’s health. Her recent, and repeated, personal experiences with heart disease – detailed in a conversation with Forbes and … Read more
The relentless surge in loneliness, exacerbated by the COVID-19 pandemic, has become a critical public health concern. New longitudinal research, published in Scientific Reports, offers a surprisingly accessible antidote: awe. This isn’t about grand adventures; the study demonstrates that even fleeting moments of awe experienced during the height of pandemic isolation were linked to reduced … Read more
A surprising trend has emerged from the inaugural EAPCI Summit 2026: despite a significant increase in the use of primary percutaneous coronary intervention (PCI) – a critical procedure for heart attack victims – mortality rates haven’t demonstrably decreased across Europe. This finding challenges long-held assumptions about the direct correlation between intervention volume and patient outcomes, … Read more
A significant update in the management of a potentially fatal condition – pulmonary embolism (PE) – has been released today, offering a much-needed roadmap for clinicians. This isn’t simply a refinement of existing practices; it reflects a growing understanding of PE’s complexities and the increasing availability of advanced treatments. The timing is critical, as hospitalizations … Read more
Eli Lilly Invests $100 Million in Inflammation Drug Rights from CSL In a significant move signaling heightened competition within the burgeoning field of inflammation-targeted therapies, Eli Lilly and Company has secured rights to develop and commercialize clazakizumab, an IL-6-blocking antibody, from CSL Limited for $100 million upfront. This strategic acquisition positions Lilly to challenge established … Read more
Nearly 80% of heart disease and stroke events in women could be prevented, yet cardiovascular disease remains the leading cause of death for women in the United States. This isn’t a failure of awareness – it’s a failure of application. We’re on the cusp of a paradigm shift, moving beyond generalized guidelines to a future … Read more
New Analysis Challenges Perceptions of Statin Side Effects A significant number of individuals who stand to benefit from cholesterol-lowering statin medications are not receiving them, and adherence rates among those prescribed the drugs are declining. A persistent concern among both patients and physicians – the potential for adverse side effects – is frequently cited as … Read more
The already vulnerable period of pregnancy and postpartum is now revealed to be a time of significantly heightened stroke risk for women with a prior history of ischemic stroke – more than doubling their chances of experiencing another event. This finding, presented at the American Stroke Association’s International Stroke Conference 2026, isn’t merely a statistical … Read more